Straits Times Index
3,315.50 +26.08 (+0.79%) Nikkei
38,726.01 +340.28 (+0.89%) Hang Seng
19,376.79 +303.08 (+1.59%) FTSE 100
8,445.80 +17.67 (+0.21%) Bitcoin USD
65,916.38 +4,099.18 (+6.63%) CMC Crypto 200
1,390.82 +122.87 (+9.69%)
AZN Oct 2024 67.500 call
| Previous close | 10.45 |
| Open | 10.15 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 67.50 |
| Expiry date | 2024-10-18 |
| Day's range | 9.85 - 10.65 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Reuters
PRESS DIGEST-British Business - May 14
The following are the top stories on the business pages of British newspapers. - Anglo American rejected a raised takeover offer of 34 billion pounds ($42.67 billion) from BHP Group on Monday, saying the world's largest listed miner "continues to significantly undervalue" the company. - JPMorgan Chase has pledged a further 40 million pounds ($50.22 million) in philanthropic investments in the UK over five years in a sign of its increasing focus on Britain.
The TelegraphUK pharma giants pledge £430m investment in France after Macron charm offensive
Britain’s two biggest pharmaceutical companies have pledged £430m of investment in France after a charm offensive by Emmanuel Macron.
ZacksBristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Bristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails to meet the primary endpoint of progression-free survival in unresectable stage III NSCLC.
